Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01219569 · ClinicalTrials.gov registry record
Effects of Sevoflurane and Propofol on Light Flashed Evoked Pupillometry
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 35
- Enrollment target
NCT01219569: Completed study, sponsored by Rutgers, The State University of New Jersey.
NCT01219569 is a clinical trial that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01219569 has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
This is a study to focus on the feasibility of using a monitor which may signal loss of visual function intraoperatively.
Interventions
- DRUG Sevoflurane
- DRUG propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-01 |
What the finished NCT01219569 record still lists
NCT01219569 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Sevoflurane is the first listed.
NCT01219569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01219569 about?
NCT01219569 is a clinical study titled "Effects of Sevoflurane and Propofol on Light Flashed Evoked Pupillometry". This is a study to focus on the feasibility of using a monitor which may signal loss of visual function intraoperatively.
What is the current status of trial NCT01219569?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2007-08. Estimated completion is 2010-01.
What interventions are being tested in trial NCT01219569?
The interventions under investigation include: Sevoflurane (DRUG), propofol (DRUG).
Who is sponsoring clinical trial NCT01219569?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia